{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:19:23Z","timestamp":1779340763511,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1038\/nbt0207-179","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T19:52:16Z","timestamp":1170877936000},"page":"179-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Turning biodefense dollars into products"],"prefix":"10.1038","volume":"25","author":[{"given":"Melanie C","family":"Trull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey V","family":"du Laney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D","family":"Dibner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnbt0207179_CR1","volume-title":"BioAbility\/BioWorld","author":"MC Trull","year":"2006","unstructured":"Trull, M.C., du Laney, T.V. & Dibner, M.D. Biodefense market report: vaccines, therapeutics, and diagnostics for bioterror agents 2006. BioAbility\/BioWorld Atlanta, GA (June 2006)."},{"key":"BFnbt0207179_CR2","unstructured":"HHS cancels VaxGen's anthrax vaccine contract. (VaxGen, Brisbane, CA, December 19, 2006). http:\/\/biz.yahoo.com\/prnews\/061219\/sftu092.html?.v=78"},{"key":"BFnbt0207179_CR3","first-page":"pA01","volume-title":"The Washington Post","author":"J Warrick","year":"2006","unstructured":"Warrick, J. The secretive fight against bioterror. The Washington Post (July 30, 2006) pA01."},{"key":"BFnbt0207179_CR4","unstructured":"http:\/\/www.cdc.gov\/ncidod\/diseases\/hepatitis\/a\/fact.htm"},{"key":"BFnbt0207179_CR5","volume-title":"BioAbility\/BioWorld","author":"MC Trull","year":"2005","unstructured":"Trull, M.C., du Laney, T.V. & Dibner, M.D. Biodefense market report: drugs and vaccines for bioterror agents. BioAbility\/BioWorld Atlanta, GA (May 2005)."},{"key":"BFnbt0207179_CR6","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1086\/504267","volume":"193","author":"TW Geisbert","year":"2006","unstructured":"Geisbert, T.W. et al. Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference. J. Infect. Dis. 193, 1650\u20131657 (2006).","journal-title":"J. Infect. Dis."},{"key":"BFnbt0207179_CR7","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","volume":"367","author":"KM Daddario-DiCaprio","year":"2006","unstructured":"Daddario-DiCaprio, K.M. et al. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet 367, 1399\u20131404 (2006).","journal-title":"Lancet"},{"key":"BFnbt0207179_CR8","unstructured":"http:\/\/www.alphavax.com\/products\/bio.aspx"},{"key":"BFnbt0207179_CR9","unstructured":"AVI BioPharma awarded $28 million biodefense research contract by Department of Defense\/DTRA. (AVI BioPharma, Portland, OR, December 4, 2006). http:\/\/www.avibio.com\/pr\/pr327.html"},{"key":"BFnbt0207179_CR10","unstructured":"http:\/\/www.bt.cdc.gov\/agent\/agentlist-category.asp"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nbt0207-179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nbt0207-179","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nbt0207-179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:52:55Z","timestamp":1744289575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt0207-179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BFnbt0207179"],"URL":"https:\/\/doi.org\/10.1038\/nbt0207-179","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}